SEC Form 4 · accession 0001762951-26-000006
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Donoghoe
Officer — EVP, CHIEF BUS/STRAT OFFICER
Period of report
Aug 14, 2026
Accepted (ET)
Aug 18, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001551152
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value | Aug 14, 2026 | M | 32,710 | $79.02 | A | 107,140 | D | |
| Common Stock, $0.01 par value | Aug 14, 2026 | S | 32,710 | $250.00 | D | 74,430 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to buy)F1 | $79.02 | Aug 14, 2026 | M | 32,710 | D | — | Feb 20, 2029 | Common Stock | 32,710 | 0 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable in annual increments of 10,904 on February 21, 2020, 10,903 on February 21, 2021, and 10,903 on February 21, 2022.